Skip to main content

Max Spaderna, MD

Academic Title:

Assistant Professor

Primary Appointment:

Psychiatry

Location:

3rd Floor

Phone (Primary):

410-328-2207

Phone (Secondary):

410-328-8070

Fax:

410-328-2223

Education and Training

2006B.A., University of Massachusetts Amherst, History 

2010M.D., Boston University School of Medicine, Medicine 

2014    Adult Psychiatry Residency, Yale University School of Medicine

Biosketch

I am part of the faculty in the Division of Addiction Research and Treatment at the University of Maryland School of Medicine. Since joining the University of Maryland in 2017, I have worked in different clinical settings within the division of Community Psychiatry and in the Psychiatric Emergency Department. In the Division of Addiction Research and Treatment, I am currently a psychiatrist for the Health and Recovery Practice (HARP), a clinic formed from a partnership with the University of Maryland’s Institute of Human Virology, Faculty Physicians, and Department of Psychiatry that collocates substance use, physical health, mental health, and infectious disease care for patients with substance use disorder. I provide opioid use disorder treatment by telemedicine to patients at the Detention Center located in Queen Anne’s County, Maryland. I provide consultation and psychiatric treatment for a cohort of patients with substance use disorders treated and followed by researchers at the Institute of Human Virology. As a researcher in opioid use disorder, my interests include suicide risk, intentional opioid overdose, psychiatric treatment, and social determinants of health.

 

Research/Clinical Keywords

Suicide risk, opioid use disorder, substance use disorders, opioid overdose, severe and persistent mental illness, social determinants of health.

Highlighted Publications

    Spaderna, M., Rosenthal, E., Kang, S.J., Eyasu, R., Ebah, E., Obgumbadiugha, O., Bijole, P., Cover, A., Davis, A., Zoltick, M., Kottilil, S., Mount, J.,Gannon, C., Stevens, J., Garrett, G., Derenoncourt, M., Liu, T., Horowitz, L., Pao, M., Kattakuzhy, S. (2025). Elevated rate of suicide risk in individuals with opioid use disorder. American Journal on Addictions, 1-10, PMID: 40069095

    Spaderna, M., Belcher, A., Smith, H., Fitzsimons, H., Coble, K., Welsh, C., Spicyn, N., Rosenthal, E., Liu, T., Weintraub, E. (2024) If you’ve done one, you’ve done ONE: Implementation outcomes and lessons learned from a novel telemedicine buprenorphine treatment program in six rural detention centers. Health Affairs, Abstract.

    Spaderna, M., Kattakuzhy, S., Kang, S.J., George, N., Bijole, P., Ebah, E., Eyasu, R., Ogbumbadiugha, O., Silk, R., Gannon, C., Davis, A., Cover, A., Gayle, B., Narayanan, S., Pao, M., Kottilil, S., Rosenthal, E. (2023). Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use. International Journal of Drug Policy, 111. 

    Spaderna, M., Bennett, M., Arnold, R., & Weintraub, E. (2021). Case Series of Patients with Opioid Use Disorder and Suicidal Ideation Treated with Buprenorphine. Clinical Practice and Cases in Emergency Medicine, 5(1), 6–10.  

    Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013). Spicing things up: Synthetic cannabinoids. Psychopharmacology, 228(4), 525–540.  

      Additional Publication Citations

      Kelly, D. L., Spaderna, M., Hodzic, V., Nair, S., Kitchen, C., Werkheiser, A. E., Powell, M. M., Liu, F., Coppersmith, G., Chen, S., & Resnik, P. (2020). Blinded Clinical Ratings of Social Media Data are Correlated with In-Person Clinical Ratings in Participants Diagnosed with Either Depression, Schizophrenia, or Healthy Controls. Psychiatry Research, 294, 113496.  

      Kelly, D. L., Spaderna, M., Hodzic, V., Coppersmith, G., Chen, S., & Resnik, P. (2021). Can language use in social media help in the treatment of severe mental illness? Current Research in Psychiatry, 1(1), 1–4.

      Israel, B., Wiprovnik, A.E., Belcher, A.M., Kleinman, M.B., Ramprashad, A., Spaderna, M., Weintraub, E. (2022). Practical Considerations for Treating Comorbid Posttraumatic Stress Disorder in the Addictions Clinic: Approaches to Clinical Care, Leadership, and Alleviating Shame. The Psychiatric Clinics of North America, 45(3), 375-414. 

      Research Interests

      Opioid use disorder, suicide risk, intentional opioid overdose, co-occurring psychiatric and substance use disorders, social determinants of health

      Clinical Specialty Details

      Severe and persistent mental illness, substance use disorders, dual diagnosis

      Awards and Affiliations

      American Board of Psychiatry and Neurology

      Addiction Medicine, American Board of Preventive Medicine

      Grants and Contracts

      07/22-06/27             Co-Inv: Principal Investigator: Elana Rosenthal

                                       5-year Programmatic Contract DC Partnership for HIV/AIDS Progress

                                       HHSN272201300022I                                  

                                       Office of AIDS Research

                                       Annual direct costs: 2,478,992.23

                                       Total direct costs: $9,629,106

       

      12/22-6/25                Co-Inv; Principal Investigator: Jay Unick

                                        National Institute of Mental Health

                                        R01 MH128781-01

                                        Bringing Health Home

                                        Annual direct costs: $750,000

                                        Total direct costs: $2,250,000

       

      07/23-02/25             Principal Investigator

                                       Service (CARES) Science to Systems Grant (SSG) program, University of Maryland Center for Addition Research, Education, and Treatment

                                       Improving the Linkage and Retention to Outpatient Psychiatric Care in Individuals with Opioid Use Disorder

                                       Annual direct costs: 25,000

                                       Total direct Costs: $50,000

       

      05/24-05/25             Principal Investigator

                                       Community Engaged Research (CEnR) Grant,

                                       University of Maryland Institute for Clinical and Translational Research      

                                        Developing a Screening Tool for Intentional Opioid Overdose                         

                                        Project ID Number: 305                                

                                        Total direct costs: $33,852

       

      09/24-09/27              Co-Inv; Principal Investigator: Melanie Bennett, 5% FTE

                                        External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting

                                         National Institute on Alcohol Abuse and Alcoholism

                                         Project ID: 1R34AA032051-01

                                         Annual direct costs: $193,750

                                         Total direct costs: $450,000

       

      9/24-9/27                    Co-Inv; Principal Investigator: Sarah Kattakuzhy, 10 % FTE                                      Evaluation of Semaglutide Safety and Tolerability in Adults with Cocaine use Disorder with and without HIV

                                           Office of AIDS Research / NIH Clinical Center 

                                           Project ID Number: 75N90024C00036 

                                           Total costs: $762,563